Recalls & Warnings May 01, 2024 FDA Warns Consumers Not to Use Ossos-Sans Supplement for Joints On April 17, 2024, the FDA warned consumers not to purchase or use Ossos-Sans, a supplement promoted to treat osteoarthritis, osteoporosis, and other conditions, because it contains undeclared drugs, including diclofenac and methocarbamol
The mechanism is systemic rather than tissue-targeted, distinguishing this class from the direct-acting tendon peptides
And while you want to be reasonable about the amounts you take, there arent cases of toxicity, says Dr
Diabetes, Obesity and Metabolism , 26(3), 445-458
Energy improves, inflammation drops, joints feel better, and sleep quality goes up